EGFR and breast carcinoma: Besides, the potential role of PTPIP51 in the sensitivity of HER2-positive breast cancer cells to EGFR-targeted TKIs, the selective recruitment to the HER2 receptor points to a specific function of PTPIP51 in the changes of cellular signaling induced by selective HER2 inhibition.